Keywords: syntropharma, raises, 4m, second, round, investment, early-stage

Syntropharma raises $2.4M in second round of investment

Article | 15 September 2008

Syntropharma, an early-stage Scottish drug developer focussed on transdermal patch delivery of reformulated generics, has raised 1.2 million ($2.1 million) in a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in